New boss same as the old. FDA’s Office of Generic Drugs makes Kathleen Uhl permanent chief
By Kurt R. Karst – The news came down on Thursday that FDA’s Center for Drug Evaluation and Research Director Janet Woodcock, M.D., named Kathleen “Cook” Uhl, M.D., as the permanent director of the Office of Generic Drugs (“OGD”). Although Dr. Uhl has manned the helm at OGD since March 2013 (see here), she has only done […]